|
TCEB3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86406445834564E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66500147003035E-12 |
| Normal-vs-Stage2 |
8.87989681785939E-12 |
| Normal-vs-Stage3 |
5.3837000002499E-07 |
| Normal-vs-Stage4 |
1.9036999999722E-06 |
| Stage1-vs-Stage2 |
2.585400E-01 |
| Stage1-vs-Stage3 |
4.637600E-01 |
| Stage1-vs-Stage4 |
8.312600E-01 |
| Stage2-vs-Stage3 |
1.526620E-01 |
| Stage2-vs-Stage4 |
3.357800E-01 |
| Stage3-vs-Stage4 |
8.038000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.54791801177635E-14 |
| Normal-vs-AfricanAmerican |
2.12241335617591E-12 |
| Normal-vs-Asian |
3.844900E-04 |
| Caucasian-vs-AfricanAmerican |
8.062800E-01 |
| Caucasian-vs-Asian |
6.206800E-01 |
| AfricanAmerican-vs-Asian |
4.918800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32036612146658E-14 |
| Normal-vs-Female |
9.88320003614263E-09 |
| Male-vs-Female |
1.657610E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.69330002744539E-10 |
| Normal-vs-Extreme_Weight |
1.64790403545112E-12 |
| Normal-vs-Obese |
3.02430303023016E-11 |
| Normal-vs-Extreme_Obese |
1.32020000043198E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.577000E-01 |
| Normal_Weight-vs-Obese |
7.307800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.696200E-01 |
| Extreme_Weight-vs-Obese |
1.488360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.735800E-01 |
| Obese-vs-Extreme_Obese |
3.392400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.141700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.95266025571073E-12 |
| Normal-vs-Age(61-80Yrs) |
1.65345515057425E-12 |
| Normal-vs-Age(81-100Yrs) |
2.268100041114E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.339500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.525700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.464400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.544000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.509800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.057600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62569957495862E-12 |
| Normal-VS-Type2 PRCC |
1.86517468137026E-14 |
| Normal-VS-KIRP CIMP |
1.679830E-01 |
| Normal-VS-Unclassified PRCC |
1.7039999966606E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.873700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.777300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.777000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.770390E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.606000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.222430E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.64140000002977E-06 |
| Normal-vs-N2 |
1.373580E-04 |
| N0-vs-N1 |
5.496200E-02 |
| N0-vs-N2 |
7.519600E-01 |
| N1-vs-N2 |
3.089200E-01 |
|
|
